Immunic, inc. reports third quarter 2023 financial results and provides corporate update
– positive interim analysis from phase 2 calliper trial showed improvements in serum neurofilament light chain for vidofludimus calcium, consistent throughout the overall progressive multiple sclerosis population and all subtypes – – notice of allowance for united states patent protecting the treatment of relapsing multiple sclerosis with vidofludimus and its salts bolsters multilayered intellectual property position – – $59.7 million in cash and cash equivalents as of september 30, 2023 expected to fund immunic into september of 2024 – – webcast to be held today, november 14, 2023, at 8:00 am et – new york , nov. 14, 2023 /prnewswire/ -- immunic, inc. (nasdaq: imux), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today announced financial results for the third quarter ended september 30, 2023, and provided a corporate update. "we have continued to make tangible progress on the clinical development of our lead asset, nuclear receptor related 1 (nurr1) activator, vidofludimus calcium (imu-838).
IMUX Ratings Summary
IMUX Quant Ranking
You've reached your free article limit.
Want To Read More Articles?
See what it all means for your stocks with premium tools
Stockprices is a weekly video covering what moved markets
this week, featuring a panel of Stockprices editors. It is published by the
close of trading on Fridays. Hosted by Nathaniel E. Baker, contributing editor,
and featuring: Aaron Task, VP Contributor Content and co-host Stockprices's Alpha
Trader podcast; Brad Olesen, VP News; Steve Alpher, Managing Editor News, co-host
Alpha Trader.
Unsubscribe From All
You successfully activated
“Only Essentials”
Confirm Upgrade
Your subscription will be moved to the annual plan. Service will automatically renew unless cancelled. No Refunds. Click upgrade to confirm.
Stockprices uses Plaid to connect you account
Connect effortlessly
Plaid lets you securely connect your financial accounts in seconds
Your data belongs to you
Plaid doesn't sell personal info, and will only use it with your permission